All sponsors

Laboratoires Thea

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-31
RECRUITING3
READOUTS ≤12 MONTHS3
Open Laboratoires Thea on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Kinezodianone R hydrochloride
NCT05389267
P1/2Active, not recruitingGlaucoma; Ocular Hypertension1202024-12-31
Slit Lamp Examination
NCT07169695
P2RecruitingModerate to Severe Vernal Keratoconjunctivitis1202027-01-21
HYPERION
NCT06891443
P3RecruitingLeber Congenital Amaurosis 10; Blindness322027-11
T10430 lower dose
NCT07522242
P2RecruitingMyopia2002027-11
LUNA
NCT06627179
P2Active, not recruitingRetinitis Pigmentosa (RP); Usher Syndrome Type 2812028-07 (+7 mo)
CAPELLA
NCT07796646
P2Not yet recruitingRetinitis Pigmentosa (RP); Usher Syndrome Type 2812030-02-28